相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。PATHOPHYSIOLOGY OF DEPRESSION: DO WE HAVE ANY SOLID EVIDENCE OF INTEREST TO CLINICIANS?
GREGOR HASLER
World Psychiatry (2015)
Correction: Acute Stress Increases Depolarization-Evoked Glutamate Release in the Rat Prefrontal/Frontal Cortex: The Dampening Action of Antidepressants
Laura Musazzi et al.
PLoS One (2014)
Characterization of the electrophysiological properties of triple reuptake inhibitors on monoaminergic neurons
Bruno P. Guiard et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2011)
A New Female Rat Animal Model for Hypoactive Sexual Desire Disorder; Behavioral and Pharmacological Evidence
Eelke M. S. Snoeren et al.
JOURNAL OF SEXUAL MEDICINE (2011)
The potential and limitations of DOV 216,303 as a triple reuptake inhibitor for the treatment of major depression: A microdialyis study in olfactory bulbectomized rats
J. Prins et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2011)
Inhibition of glutamate release by bupropion in rat cerebral cortex nerve terminals
Tzu Yu Lin et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2011)
Depression and Hypothalamic-Pituitary-Adrenal Activation: A Quantitative Summary of Four Decades of Research
Cinnamon Stetler et al.
PSYCHOSOMATIC MEDICINE (2011)
Dopamine signals for reward value and risk: basic and recent data
Wolfram Schultz
BEHAVIORAL AND BRAIN FUNCTIONS (2010)
Synthesis and pharmacological evaluation of 3-aryl-3-azolylpropan-1-amines as selective triple serotonin/norepinephrine/dopamine reuptake inhibitors
Ki-Ho Lee et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
2-Substituted N-aryl piperazines as novel triple reuptake inhibitors for the treatment of depression
David S. Carter et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
Subjective and Objective Effects of the Novel Triple Reuptake Inhibitor Tesofensine in Recreational Stimulant Users
K. A. Schoedel et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2010)
Relevance of Norepinephrine-Dopamine Interactions in the Treatment of Major Depressive Disorder
Mostafa El Mansari et al.
CNS NEUROSCIENCE & THERAPEUTICS (2010)
Role of Serotonin in Central Dopamine Dysfunction
Giuseppe Di Giovanni et al.
CNS NEUROSCIENCE & THERAPEUTICS (2010)
The putative antidepressant DOV 216,303, a triple reuptake inhibitor, increases monoamine release in the prefrontal cortex of olfactory bulbectomized rats
Jolanda Prins et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2010)
The novel triple monoamine reuptake inhibitor tesofensine induces sustained weight loss and improves glycemic control in the diet-induced obese rat: Comparison to sibutramine and rimonabant
Henrik H. Hansen et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2010)
Antidepressant Drug Effects and Depression Severity A Patient-Level Meta-analysis
Jay C. Fournier et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
Identifying Depressive Subtypes in a Large Cohort Study: Results From the Netherlands Study of Depression and Anxiety (NESDA)
Femke Lamers et al.
JOURNAL OF CLINICAL PSYCHIATRY (2010)
1-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes and 6-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes: A New Series of Potent and Selective Triple Reuptake Inhibitors
Fabrizio Micheli et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
6-(3,4-Dichlorophenyl)-1-[(Methyloxy)methyl]-3-azabicyclo[4.1.0]heptane: A New Potent and Selective Triple Reuptake Inhibitor
Fabrizio Micheli et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
The Novel Triple Reuptake Inhibitor JZAD-IV-22 Exhibits an Antidepressant Pharmacological Profile without Locomotor Stimulant or Sensitization Properties
Barbara J. Caldarone et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)
The neurobiological properties of tianeptine (Stablon): from monoamine hypothesis to glutamatergic modulation
B. S. McEwen et al.
MOLECULAR PSYCHIATRY (2010)
Dopamine D2 receptors in addiction-like reward dysfunction and compulsive eating in obese rats
Paul M. Johnson et al.
NATURE NEUROSCIENCE (2010)
Agomelatine, the first melatonergic antidepressant: discovery, characterization and development (vol 9, pg 628, 2010)
Christian de Bodinat et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
Bupropion as the treatment of choice in depression associated with Parkinson's disease and it's various treatments
Sergey Raskin et al.
MEDICAL HYPOTHESES (2010)
Structural and cognitive deficits in remitting and non-remitting recurrent depression: A voxel-based morphometric study
Cheng-Ta Li et al.
NEUROIMAGE (2010)
Neurocircuitry of Addiction
George F. Koob et al.
NEUROPSYCHOPHARMACOLOGY (2010)
Neurocircuitry of Mood Disorders
Joseph L. Price et al.
NEUROPSYCHOPHARMACOLOGY (2010)
NEONATAL MATERNAL SEPARATION EXACERBATES THE REWARD-ENHANCING EFFECT OF ACUTE AMPHETAMINE ADMINISTRATION AND THE ANHEDONIC EFFECT OF REPEATED SOCIAL DEFEAT IN ADULT RATS
A. Der-Avakian et al.
NEUROSCIENCE (2010)
Psychostimulant-like discriminative stimulus and locomotor sensitization properties of the wake-promoting agent modafinil in rodents
Neil E. Paterson et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2010)
Intermittent and continuous swim stress-induced behavioral depression: sensitivity to norepinephrine- and serotonin-selective antidepressants
Robert C. Drugan et al.
PSYCHOPHARMACOLOGY (2010)
Subtyping Major Depressive Disorder
Pesach Lichtenberg et al.
PSYCHOTHERAPY AND PSYCHOSOMATICS (2010)
mTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA Antagonists
Nanxin Li et al.
SCIENCE (2010)
A new strategy for antidepressant prescription
Francis Lavergne et al.
FRONTIERS IN NEUROSCIENCE (2010)
Large-scale trial suggests ethosuximide as best treatment for absence epilepsy
[Anonymous]
FUTURE NEUROLOGY (2010)
The Neuropsychopharmacology of Fronto-Executive Function: Monoaminergic Modulation
T.W. Robbins et al.
Annual Review of Neuroscience (2009)
The functional neuroanatomy of depression: Distinct roles for ventromedial and dorsolateral prefrontal cortex
Michael Koenigs et al.
BEHAVIOURAL BRAIN RESEARCH (2009)
Prospect of a Dopamine Contribution in the Next Generation of Antidepressant Drugs: The Triple Reuptake Inhibitors
Bruno P. Guiard et al.
CURRENT DRUG TARGETS (2009)
Interaction of dopamine D1 with NMDA NR1 receptors in rat prefrontal cortex
Maria Sol Kruse et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2009)
Current investigational drugs for major depression
Shrinivas K. Kulkarni et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2009)
Selegiline transdermal system: a novel treatment option for major depressive disorder
Jayasree J. Nandagopal et al.
EXPERT OPINION ON PHARMACOTHERAPY (2009)
Effects of Modafinil on Dopamine and Dopamine Transporters in the Male Human Brain Clinical Implications
Nora D. Volkow et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Preclinical Evaluation of the Abuse Potential of the Analgesic Bicifadine
Katherine L. Nicholson et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
Dual- and Triple-Acting Agents for Treating Core and Co-morbid Symptoms of Major Depression: Novel Concepts, New Drugs
Mark J. Millan
NEUROTHERAPEUTICS (2009)
Global Brain Gene Expression Analysis Links Glutamatergic and GABAergic Alterations to Suicide and Major Depression
Adolfo Sequeira et al.
PLOS ONE (2009)
Potencies of Cocaine Methiodide on Major Cocaine Targets in Mice
Erik R. Hill et al.
PLOS ONE (2009)
Unfaithful neurotransmitter transporters: Focus on serotonin uptake and implications for antidepressant efficacy
Lynette C. Daws
PHARMACOLOGY & THERAPEUTICS (2009)
Acute stress enhances glutamatergic transmission in prefrontal cortex and facilitates working memory
Eunice Y. Yuen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
From Real-World Events to Psychosis: The Emerging Neuropharmacology of Delusions
Paul D. Morrison et al.
SCHIZOPHRENIA BULLETIN (2009)
From high anxiety trait to depression: a neurocognitive hypothesis
Carmen Sandi et al.
TRENDS IN NEUROSCIENCES (2009)
Tesofensine (NS 2330), a monoamine reuptake inhibitor, in patients with advanced Parkinson disease and motor fluctuations
Olivier Rascol et al.
ARCHIVES OF NEUROLOGY (2008)
Novel 3,3-disubstituted pyrrolidines as selective triple serotonin/norepinephrine/dopamine reuptake inhibitors
Linda M. Bannwart et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2008)
Rapid changes in hippocampal CA1 pyramidal cell function via pre- as well as postsynaptic membrane mineralocorticoid receptors
J. E. Olijslagers et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2008)
In-vitro and in-vivo characterization of JNJ-7925476, a novel triple monoamine uptake inhibitor
Leah Aluisio et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2008)
A meta-analysis of clinical trials comparing reboxetine, a norepinephrine reuptake inhibitor, with selective serotonin reuptake inhibitors for the treatment of major depressive disorder
George I. Papakostas et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2008)
The triple monoaminergic reuptake inhibitor DOV 216,303 has antidepressant effects in the rat olfactory bulbectomy model and lacks sexual side effects
M. E. Breuer et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2008)
Dopamine receptors regulate NMDA receptor surface expression in prefrontal cortex neurons
Can Gao et al.
JOURNAL OF NEUROCHEMISTRY (2008)
Antidepressant-Like Pharmacological Profile of a Novel Triple Reuptake Inhibitor, (1S, 2S)-3-(Methylamino)-2-(naphthalen-2-yl)-1-phenylpropan-1-ol (PRC200-SS)
Yanqi Liang et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
Cross-Talk between Dopaminergic and Noradrenergic Systems in the Rat Ventral Tegmental Area, Locus Ceruleus, and Dorsal Hippocampus
Bruno P. Guiard et al.
MOLECULAR PHARMACOLOGY (2008)
Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders
Gerard Sanacora et al.
NATURE REVIEWS DRUG DISCOVERY (2008)
Science & society - A common neurobiology for pain and pleasure
Siri Leknes et al.
NATURE REVIEWS NEUROSCIENCE (2008)
From inflammation to sickness and depression: when the immune system subjugates the brain
Robert Dantzer et al.
NATURE REVIEWS NEUROSCIENCE (2008)
Repeated administration of imipramine attenuates glutamatergic transmission in rat frontal cortex
K. Tokarski et al.
NEUROSCIENCE (2008)
Triple Reuptake Inhibitors: A Premise and Promise
David M. Marks et al.
PSYCHIATRY INVESTIGATION (2008)
Affective neuroscience of pleasure: reward in humans and animals
Kent C. Berridge et al.
PSYCHOPHARMACOLOGY (2008)
Initial severity and antidepressant benefits: A meta-analysis of data submitted to the food and drug administration
Irving Kirsch et al.
PLOS MEDICINE (2008)
Stress, depression, and neuroplasticity: A convergence of mechanisms
Christopher Pittenger et al.
NEUROPSYCHOPHARMACOLOGY (2008)
Coadministration of modafinil and a selective serotonin reuptake inhibitor from the initiation of treatment of major depressive disorder with fatigue and sleepiness - A double-blind, placebo-controlled study
Boadie W. Dunlop et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2007)
Eating for pleasure or calories
Huiyuan Zheng et al.
CURRENT OPINION IN PHARMACOLOGY (2007)
Effect of DOV 102,677 on the volitional consumption of ethanol by Myers' high ethanol-preferring rat
Brian A. McMillen et al.
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2007)
Antidepressant treatments and function of glutamate ionotropic receptors mediating amine release in hippocampus
Anna Pittaluga et al.
NEUROPHARMACOLOGY (2007)
The other face of depression, reduced positive affect: the role of catecholamines in causation and cure
David Nutt et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2007)
Characterization of the Antinociceptive actions of bicifadine in models of acute, persistent, and chronic pain
Anthony S. Basile et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Long-term behavioral changes after cessation of chronic antidepressant treatment in olfactory bulbectomized rats
Megan E. Breuer et al.
BIOLOGICAL PSYCHIATRY (2007)
Dopaminergic function in depressed patients with affective flattening or with impulsivity:: [18F]fluoro-L-dopa positron emission tomography study with voxel-based analysis
Veronique Bragulat et al.
PSYCHIATRY RESEARCH-NEUROIMAGING (2007)
Neuronal proteins involved in synaptic targeting of AMPA receptors in rat hippocampus by antidepressant drugs
Rebeca Martinez-Turrillas et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
Randomized trial of the triple monoamine reuptake inhibitor NS 2330 (Tesofensine) in early Parkinson's disease
Robert A. Hauser et al.
MOVEMENT DISORDERS (2007)
Expression of brain derived neurotrophic factor, activity-regulated cytoskeleton protein mRNA, and enhancement of adult hippocampal neurogenesis in rats after sub-chronic and chronic treatment with the triple monoamine re-uptake inhibitor tesofensine
Marianne H. Larsen et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2007)
Antidepressant-like effects of novel triple reuptake inhibitors, PRC025 and PRC050
Amanda M. Shaw et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2007)
Triple uptake inhibitors: therapeutic potential in depression and beyond
Zhengming Chen et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2007)
The role of dopamine in the pathophysiology of depression
Boadie W. Dunlop et al.
ARCHIVES OF GENERAL PSYCHIATRY (2007)
Resolution of sleepiness and fatigue in major depressive disorder: A comparison of bupropion and the selective serotonin reuntake inhibitors
George I. Papakostas et al.
BIOLOGICAL PSYCHIATRY (2006)
Effects of the dopamine agonist pramipexole on depression, anhedonia and motor functioning in Parkinson's disease
Matthias R. Lemke et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2006)
A slow-onset, long-duration indanamine monoamine reuptake inhibitor as a potential maintenance pharmacotherapy for psychostimulant abuse: Effects in laboratory rat models relating to addiction
Eliot L. Gardner et al.
NEUROPHARMACOLOGY (2006)
The mesolimbic dopamine reward circuit in depression
Eric J. Nestler et al.
BIOLOGICAL PSYCHIATRY (2006)
Preclinical and clinical pharmacology of DOV 216,303, a triple reuptake inhibitor
Phil Skolnick et al.
CNS DRUG REVIEWS (2006)
Multi-target strategies for the improved treatment of depressive states: Conceptual foundations and neuronal substrates, drug discovery and therapeutic application
MJ Millan
PHARMACOLOGY & THERAPEUTICS (2006)
Regulation of editing and expression of glutamate α-amino-propionic-acid (AMPA)/kainate receptors by antidepressant drugs
A Barbon et al.
BIOLOGICAL PSYCHIATRY (2006)
Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression
AJ Rush et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Medication augmentation after the failure of SSRIs for depression
MH Trivedi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Pramipexole: Augmentation in the treatment of depressive symptoms
S Gupta et al.
CNS SPECTRUMS (2006)
Characterization of nicotine's ability to serve as a negative feature in a Pavlovian appetitive conditioning task in rats
RA Bevins et al.
PSYCHOPHARMACOLOGY (2006)
Mineralocorticoid receptors are indispensable for nongenomic modulation of hippocampal glutamate transmission by corticosterone
H Karst et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Functional neuroanatomical substrates of altered reward processing in major depressive disorder revealed by a dopaminergic probe
LK Tremblay et al.
ARCHIVES OF GENERAL PSYCHIATRY (2005)
Selective cortical VGLUT1 increase as a marker for antidepressant activity
L Moutsimilli et al.
NEUROPHARMACOLOGY (2005)
Neural systems of reinforcement for drug addiction: from actions to habits to compulsion
BJ Everitt et al.
NATURE NEUROSCIENCE (2005)
Altered cortical glutamatergic and GABAergic signal transmission with glial involvement in depression
PV Choudary et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Antiinflammatory action of glucocorticoids - New mechanisms for old drugs
T Rhen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Dopamine receptor stimulation modulates AMPA receptor synaptic insertion in prefrontal cortex neurons
X Sun et al.
JOURNAL OF NEUROSCIENCE (2005)
Evidence for increased expression of the vesicular glutamate transporter, VGLUT1, by a course of antidepressant treatment
RM Tordera et al.
JOURNAL OF NEUROCHEMISTRY (2005)
Ropinirole in treatment-resistant depression: A 16-week pilot study
P Cassano et al.
CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE (2005)
Chronic antidepressants reduce depolarization-evoked glutamate release and protein interactions favoring formation of SNARE complex in hippocampus
G Bonanno et al.
JOURNAL OF NEUROSCIENCE (2005)
The many faces of fatigue in major depressive disorder
K Demyttenaere et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2005)
Don't worry 'B' happy!: a role for GABA(B) receptors in anxiety and depression
JF Cryan et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2005)
SNRIs: The pharmacology, clinical efficacy, and tolerability in comparison with other classes of antidepressants
SM Stahl et al.
CNS SPECTRUMS (2005)
Tonic and phasic alteration in amygdala 5-HT, glutamate and GABA transmission after prefrontal cortex damage in rats
LE Gonzalez et al.
BRAIN RESEARCH (2004)
Onset and early behavioral effects of pharmacologically different antidepressants and placebo in depression
MM Katz et al.
NEUROPSYCHOPHARMACOLOGY (2004)
Preliminary randomized, double-blind, placebo-controlled trial of pramipexole added to mood stabilizers for treatment-resistant bipolar depression
JF Goldberg et al.
AMERICAN JOURNAL OF PSYCHIATRY (2004)
Dysregulation in the suicide brain:: mRNA expression of corticotropin-releasing hormone receptors and GABAA receptorsubunits in frontal cortical brain region
Z Merali et al.
JOURNAL OF NEUROSCIENCE (2004)
DOV 216,3039 a 'Triple reuptake inhibitor: Safety, tolerability, and pharmacokinetic profile
B Beer et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2004)
Molecular mechanisms of neuroplasticity and pharmacological implications: the example of tianeptine
BS McEwen et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2004)
Subtype-specific alterations of γ-aminobutyric acid and glutamate in patients with major depression
G Sanacora et al.
ARCHIVES OF GENERAL PSYCHIATRY (2004)
Subjective effects of slow-release bupropion versus caffeine as determined in a quasi-naturalistic setting
G Zernig et al.
PHARMACOLOGY (2004)
Serotonin transporter occupancy of five selective serotonin Reuptake inhibitors at different doses:: An [11C]DASB positron emission tomography study
JH Meyer et al.
AMERICAN JOURNAL OF PSYCHIATRY (2004)
Broad spectrum antidepressants: Is more better for the treatment of depression?
P Skolnick et al.
LIFE SCIENCES (2003)
In vivo activity of bupropion at the human dopamine transporter as measured by positron emission tomography
SM Learned-Coughlin et al.
BIOLOGICAL PSYCHIATRY (2003)
Afferent modulation of dopamine neuron firing differentially regulates tonic and phasic dopamine transmission
SB Floresco et al.
NATURE NEUROSCIENCE (2003)
Fluoxetine depresses glutamate exocytosis in the rat cerebrocortical nerve terminals (synaptosomes) via inhibition of P/Q-type Ca2+ channels
SJ Wang et al.
SYNAPSE (2003)
Escitalopram, the S-(+)-enantiomer of citalopram, is a selective serotonin reuptake inhibitor with potent effects in animal models predictive of antidepressant and anxiolytic activities
C Sánchez et al.
PSYCHOPHARMACOLOGY (2003)
Enhancing neuronal plasticity and cellular resilience to develop novel, improved therapeutics for difficult-to-treat depression
HK Manji et al.
BIOLOGICAL PSYCHIATRY (2003)
The locus coeruleus-noradrenergic system: modulation of behavioral state and state-dependent cognitive processes
CW Berridge et al.
BRAIN RESEARCH REVIEWS (2003)
Dopamine: a potential substrate for synaptic plasticity and memory mechanisms
TM Jay
PROGRESS IN NEUROBIOLOGY (2003)
Modafinil increases histamine release in the anterior hypothalamus of rats
T Ishizuka et al.
NEUROSCIENCE LETTERS (2003)
Antidepressant-like actions of DOV 21,947: a triple reuptake inhibitor
P Skolnick et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2003)
Animal models of anxiety and their molecular dissection
J Flint
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2003)
GABAergic dysfunction in mood disorders
P Brambilla et al.
MOLECULAR PSYCHIATRY (2003)
Dopamine, but not norepinephrine or serotonin, reuptake inhibition reverses motor deficits in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated primates
MJ Hansard et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
The need to feed: Homeostatic and hedonic control of eating
CB Saper et al.
NEURON (2002)
Neural and Behavioral substrates of mood and mood regulation
RJ Davidson et al.
BIOLOGICAL PSYCHIATRY (2002)
Bupropion occupancy of the dopamine transporter is low during clinical treatment
JH Meyer et al.
PSYCHOPHARMACOLOGY (2002)
Interaction between glucocorticoid hormones, stress and psychostimulant drugs
M Marinelli et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2002)
Probing brain reward system function in major depressive disorder - Altered response to dextroamphetamine
LK Tremblay et al.
ARCHIVES OF GENERAL PSYCHIATRY (2002)
Involvement of striatal and extrastriatal DARPP-32 in biochemical and behavioral effects of fluoxetine (Prozac)
P Svenningsson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Antidepressant mechanisms: functional and molecular correlates of excitatory amino acid neurotransmission
CA Stewart et al.
MOLECULAR PSYCHIATRY (2002)
Glutamate and GABA systems as targets for novel antidepressant and mood-stabilizing treatments
JH Krystal et al.
MOLECULAR PSYCHIATRY (2002)
Organization of the stress system and its dysregulation in melancholic and atypical depression: high vs low CRH/NE states
PW Gold et al.
MOLECULAR PSYCHIATRY (2002)
Extracellular histamine levels in the feline preoptic/anterior hypothalamic area during natural sleep-wakefulness and prolonged wakefulness: An in vivo microdialysis study
RE Strecker et al.
NEUROSCIENCE (2002)
The sleep switch: hypothalamic control of sleep and wakefulness
CB Saper et al.
TRENDS IN NEUROSCIENCES (2001)
A commentary on the neurobiology of the hypocretin/orexin system
E Mignot
NEUROPSYCHOPHARMACOLOGY (2001)
Response and remission rates in different subpopulations with major depressive disorder administered venlafaxine, selective serotonin reuptake inhibitors, or placebo
AR Entsuah et al.
JOURNAL OF CLINICAL PSYCHIATRY (2001)
Reduced dopaminergic activity in depressed suicides
S Watson et al.
PSYCHONEUROENDOCRINOLOGY (2001)
Acute doses of d-amphetamine and bupropion increase cigarette smoking
MS Cousins et al.
PSYCHOPHARMACOLOGY (2001)
The cellular neurobiology of depression
HK Manji et al.
NATURE MEDICINE (2001)
The prefrontal cortex - An update: time is of the essence
JM Fuster
NEURON (2001)
Reduced dopaminergic activity in depressed suicides
W Pitchot et al.
PSYCHONEUROENDOCRINOLOGY (2001)
Remission rates during treatment with venlafaxine or selective serotonin reuptake inhibitors
ME Thase et al.
BRITISH JOURNAL OF PSYCHIATRY (2001)
Corticosteroids in relation to fear, anxiety and psychopathology
SM Korte
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2001)
Decreased presynaptic dopamine function in the left caudate of depressed patients with affective flattening and psychomotor retardation
MLP Martinot et al.
AMERICAN JOURNAL OF PSYCHIATRY (2001)
The possibility of neurotoxicity in the hippocampus in major depression: A primer on neuron death
RM Sapolsky
BIOLOGICAL PSYCHIATRY (2000)
Neuroimaging studies of mood disorders
WC Drevets
BIOLOGICAL PSYCHIATRY (2000)
Sequential improvement of anxiety, depression and anhedonia with sertraline treatment in patients with major depression
P Boyer et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2000)
Dopaminergic function and the cortisol response to dexamethasone in psychotic depression
F Duval et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2000)
Pronounced and sustained central hypernoradrenergic function in major depression with melancholic features: Relation to hypercortisolism and corticotropin-releasing hormone
ML Wong et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Imipramine and phenelzine decrease glutamate overflow in the prefrontal cortex - A possible mechanism of neuroprotection in major depression?
AT Michael-Titus et al.
NEUROSCIENCE (2000)
分享论文
